Nutrien (NYSE:NTR – Get Free Report) had its price target raised by investment analysts at UBS Group from $52.00 to $56.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential upside of 0.74% from the stock’s current price.
A number of other research firms have also recently commented on NTR. Berenberg Bank boosted their price target on shares of Nutrien from $54.00 to $59.00 and gave the stock a “buy” rating in a research note on Tuesday, April 15th. Oppenheimer reduced their target price on Nutrien from $60.00 to $58.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. raised Nutrien from an “underweight” rating to a “neutral” rating and lifted their price target for the stock from $40.00 to $50.00 in a research note on Monday, January 13th. Piper Sandler raised their price objective on Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Finally, CIBC upped their target price on Nutrien from $64.00 to $66.00 and gave the stock an “outperformer” rating in a research note on Tuesday, February 25th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $59.93.
Read Our Latest Analysis on NTR
Nutrien Stock Up 1.5 %
Nutrien (NYSE:NTR – Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The firm had revenue of $4.67 billion during the quarter, compared to the consensus estimate of $5.16 billion. During the same period in the previous year, the company posted $0.46 EPS. The company’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities analysts predict that Nutrien will post 3.72 EPS for the current fiscal year.
Institutional Investors Weigh In On Nutrien
A number of large investors have recently made changes to their positions in NTR. Vanguard Group Inc. lifted its stake in Nutrien by 7.1% in the first quarter. Vanguard Group Inc. now owns 21,191,003 shares of the company’s stock worth $1,051,709,000 after acquiring an additional 1,412,503 shares during the period. Dodge & Cox lifted its position in shares of Nutrien by 0.3% in the 4th quarter. Dodge & Cox now owns 12,523,259 shares of the company’s stock worth $560,416,000 after purchasing an additional 40,800 shares during the period. Silchester International Investors LLP boosted its stake in shares of Nutrien by 9.5% during the 4th quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company’s stock valued at $523,268,000 after purchasing an additional 1,009,895 shares in the last quarter. First Eagle Investment Management LLC increased its position in shares of Nutrien by 0.8% during the fourth quarter. First Eagle Investment Management LLC now owns 9,529,311 shares of the company’s stock valued at $426,436,000 after buying an additional 77,174 shares during the period. Finally, Mackenzie Financial Corp raised its stake in Nutrien by 0.7% in the first quarter. Mackenzie Financial Corp now owns 7,855,609 shares of the company’s stock worth $389,860,000 after buying an additional 54,918 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
- Five stocks we like better than Nutrien
- How to trade using analyst ratings
- Google Is Betting Big on Nuclear Reactors—Should You?
- Investing in Construction Stocks
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Energy and Oil Stocks Explained
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.